Prof Michael Xianfeng Chen received his MSc and PhD from National University of Singapore, and University of Oxford, respectively. He is currently working in the Institute for Bioengineering in the School of Engineering at The University of Edinburgh as a Professor, Chair of Therapetic Engineering, and also serves as the Director of Industry Engagement of School of Engineering. Prof Chen’s research is focused on biomaterials, biomedical engineering, and the application of nanomaterials in biology and medicine. In these areas, he has been working on physical (microneedle & nanoneedle arrays) and chemical (nanomedicine) tools for drug delivery, 3D printed microfluidic devices, and biosensing. He has published over 130 papers in peer-reviewed international journals, majority in field top journals. These publications generated a google scholar h-index of 59 and >9000 citations. Additionally, he has 2 book chapters and 12 granted patents in drug delivery technologies in various major countries and regions, primarily in the USA.

Dr. Seungpyo Hong is the Milton J. Henrichs Chair and Professor of Pharmaceutical Sciences and Director of Wisconsin Center for NanoBioSystems (WisCNano) at University of Wisconsin-Madison (UW-Madison). He holds appointments as Adjunct Professor at University of Texas Southwestern Medical Center, University of Illinois Chicago (UIC), and Yonsei University, Seoul, Korea, while serving as Associate Editor for Nanomedicine: Nanotechnology, Biology and Medicine of Elsevier. Dr. Hong is also active in entrepreneurship, co-founding a biotech startup called Capio Biosciences. He graduated from Hanyang University in Seoul, Korea with B.S. and M.S. degrees in polymer engineering in 1999 and 2001, respectively. He then received his PhD in Macromolecular Science and Engineering from University of Michigan in 2006 and joined MIT as a postdoctoral associate in the laboratory of Prof. Robert Langer. From 2008 to 2014, he was an Assistant Professor at UIC where he was promoted to Associate Professor with tenure in 2014, and subsequently joined the UW-Madison faculty as Full Professor in 2016. To date, Prof. Hong’s research has culminated in over 120 peer-reviewed articles that have accumulated a total of over 21,000 citations (h-index: 54), 1 co-edited book, 8 book chapters, and 23 issued or pending patents, while delivering over 200 invited talks worldwide. His scientific contributions have been well recognized, resulting in him receiving honors, including 2022 Inducted Fellow of American Institute for Medical and Biological Engineering (AIMBE) and 2012 New Investigator Award from American Association of Pharmaceutical Scientists (AAPS).